Becton, Dickinson and Co. share price logo

Becton, Dickinson and Co.

NASDAQ: BDX

Large Cap

$141.61

-3.55

(-2.45%)

as on

Becton, Dickinson and Co. Stock Performance

as on June 18, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $140.63
    $145.47
    downward going graph

    0.69%

    Downside

    2.73%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $140.63
    $213.08
    downward going graph

    0.69%

    Downside

    50.47%

    Upside

    downward going graph

Becton, Dickinson and Co. share price movements today

Previous Close
$145.16
Open
$144.42
Volume
1.7M
Day's Low - High
$140.63 - $145.47
52 Week Low - High
$140.63 - $213.08

Becton, Dickinson and Co. Historical Returns

1 Month Return
-0.52 %
3 Month Return
-10.42 %
1 Year Return
-16 %
3 Year Return
-45.25 %
5 Year Return
-41.13 %

Becton, Dickinson and Co. Stock Fundamentals & Key Indicators

Check Becton, Dickinson and Co. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.0B

EPS (TTM)

12.5374

Dividend Yield

2.87%

Quarterly Earnings Growth YOY

0.29%

PE Ratio (TTM)

25.33

Industry PE ratio

26.366153846153846

PEG Ratio

1.1074

EBITDA

6.2B

Revenue (TTM)

22.2B

Profit Margin

5.12%

Return On Equity TTM

6.67%

Becton, Dickinson and Co. Stock Valuation

Track how Becton, Dickinson and Co. P/E has moved over time to understand its valuation trends.

Becton, Dickinson and Co. in the last 5 years

  • Overview

  • Trends

Lowest (12.84x)

June 30, 2025

Today (25.33x)

June 18, 2026

Industry (26.37x)

June 18, 2026

Highest (22.10x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 25.33x

Becton, Dickinson and Co. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Becton, Dickinson and Co. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Becton, Dickinson and Co. image
Becton, Dickinson and Co.
BUY$40.0B-41.13%25.335.12%2.87%
Intuitive Surgical Inc. image
Intuitive Surgical Inc.
BUY$147.7B37.28%50.7428.15%NA
Alcon Inc. image
Alcon Inc.
BUY$32.3B-8.68%39.697.70%0.54%
Medline Inc. Class A image
Medline Inc. Class A
NA$65.3BNA32.133.32%NA

Stock Returns calculator for Becton, Dickinson and Co. Stock including INR - Dollar returns

The Becton, Dickinson and Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Becton, Dickinson and Co. investment value today

Current value as on today

₹91,959

Returns

-₹8,041

(-8.04%)

Returns from Becton, Dickinson and Co. Stock

-₹16,003 (-16%)

Dollar Impact

₹7,962 (+7.96%)

Analyst Recommendation on Becton, Dickinson and Co. Stock

Based on 20 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 20 analysts, 70% of analysts recommend a 'BUY' rating for Becton, Dickinson and Co.. Average target price of $180.69

Becton, Dickinson and Co. Share Price Target

Get share price movements and forecasts by analysts on Becton, Dickinson and Co..

What analysts predicted

21.63%UPSIDE

Target Price

$180.69

Current Price

$141.61

Analyzed by

20 Analysts

Target

$180.69

Becton, Dickinson and Co. target price $180.69, a slight upside of 21.63% compared to current price of $141.61. According to 20 analysts rating.

Indian Investors' Interest in Becton, Dickinson and Co. Stock

Search interest for Becton, Dickinson and Co. Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:64% versus previous 30 day period

Becton, Dickinson and Co. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
4,706
5,045
4,990
5,437
5,168
5,272
5,509
5,890
5,252
4,714
Gross Profit
2,027
2,304
2,307
2,487
2,235
2,257
2,634
2,798
2,344
2,154
Operating Income
439
734
602
622
453
546
882
697
594
94
EBITDA
1,031
1,329
1,205
1,255
1,068
1,122
1,473
1,294
1,208
709
Interest Expense
111
125
137
155
155
151
152
155
107
149
Depreciation
561
571
568
586
607
608
618
629
614
520
Income Before Tax
359
633
500
514
306
363
703
510
487
39
Income Tax Expense
77
96
13
114
3
55
129
17
105
76
Net Income
281
537
487
400
303
308
574
493
382
-311
Net Profit Margin
5.97%
10.64%
9.76%
7.36%
5.86%
5.84%
10.42%
8.37%
7.27%
-6.60%

Becton, Dickinson and Co. Annual Profit & Loss

All numbers in Millions USD

Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
12,483
12,093
15,983
17,290
16,074
19,131
18,870
19,372
20,178
21,839
Gross Profit
5,991
5,965
7,269
8,288
6,798
8,631
8,477
8,170
9,125
9,924
Operating Income
1,430
1,522
1,509
1,760
912
2,250
2,282
2,111
2,397
2,578
EBITDA
2,576
2,585
3,857
4,068
3,057
4,391
4,410
4,402
4,819
4,957
Interest Expense
388
521
706
639
528
469
398
452
528
613
Depreciation
-
1,088
1,978
2,253
2,154
2,273
2,229
2,288
2,286
2,462
Income Before Tax
1,074
976
1,173
1,176
414
1,692
1,783
1,662
2,005
1,882
Income Tax Expense
97
-124
862
-57
62
88
148
132
300
204
Net Income
976
1,100
311
1,233
874
2,092
1,779
1,484
1,705
1,678
Net Profit Margin
7.82%
9.10%
1.95%
7.13%
5.44%
10.94%
9.43%
7.66%
8.45%
7.68%

Becton, Dickinson and Co. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
537
487
421
303
330
552
493
382
-310
Operating Cash Flow
515
1,264
1,178
693
164
1,219
1,354
657
671
Investing Cash Flow
-1,056
-288
-3,937
204
-192
-336
-494
-183
-139
Financing Cash Flow
1,705
1,120
124
-1,928
-39
-841
-809
-302
-414
Change in Cash
1,160
2,093
-2,631
-1,043
-66
50
53
173
120

Becton, Dickinson and Co. Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
1,100
311
1,220
874
2,092
1,779
1,530
1,705
1,678
Operating Cash Flow
2,550
2,865
3,330
3,539
4,647
2,633
2,989
3,798
3,430
Investing Cash Flow
-883
-15,829
-741
-1,232
-1,880
-3,220
-716
-5,514
-818
Financing Cash Flow
10,978
-57
-3,224
22
-3,306
-591
-1,957
2,087
-3,617
Change in Cash
12,638
-13,039
-646
2,327
-525
-1,233
322
375
-1,005

Mutual Funds that own Becton, Dickinson and Co. Stock

Check out the Mutual Funds with significant holdings in Becton, Dickinson and Co..

Global Institutional Holdings in Becton, Dickinson and Co.

Funds
Holdings
BlackRock Inc
9.49%
Vanguard Group Inc
13.31%
State Street Corp
5.02%
Geode Capital Management, LLC
2.58%
Wellington Management Company LLP
2.4%
See all

Becton, Dickinson and Co. News & Key Events

  • img

    Today's Timeline - 18 May

    Mon, 04:20 PM

    -

    Peter Menziuso appointed EVP and President of BD Interventional, effective June 1, bringing extensive healthcare leadership experience.

    Mon, 07:10 PM

    -

    Becton, Dickinson reports better-than-expected Q2 results; analysts maintain Moderate Buy rating with price target raised to $204.

Insights on Becton, Dickinson and Co.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Becton, Dickinson and Co. has experienced a decline in revenue for the past three quarters. Specifically, their revenue decreased from $5.89 billion to $4.71 billion, indicating an average decrease of 10.5% per quarter.

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Becton, Dickinson and Co. has seen a decline in its net profit over the last four quarters. The net profit fell from $574.0 million to -$311.0 million, representing an average decrease of 72.7% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BDX stock has moved down by -3.9%

About Becton, Dickinson and Co.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care
OrganisationBecton, Dickinson and Co.
Headquarters1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880
IndustryMedical Instruments & Supplies
CEOMr. Thomas E. Polen Jr.
E-voting on sharesClick here to vote

Key Management of Becton, Dickinson and Co.

Name

Title

Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.

Senior VP & Chief Scientific Officer

Ms. Denise Russell Fleming

Executive Vice President & Chief Information Officer

Ms. Meera Gopalakrishnan

Senior VP & Global Chief Marketing Officer

Mr. Michael Garrison

Executive VP & President of Medical Segment and BioPharma Systems Segments

Mr. Vitor Roque

Executive VP & CFO

Ms. Elizabeth McCombs

Executive VP & CTO

Ms. Lanesha T. Minnix J.D.

Executive VP & General Counsel

Carla Burigatto

Senior VP & Chief Communications Officer

Mr. Thomas E. Polen Jr.

President, CEO & Chairman

Mr. Michael C. Feld

Executive VP & Chief Revenue Officer

FAQs

What is Becton, Dickinson and Co. share price today?

Becton, Dickinson and Co. share price today is $141.61 as on at the close of the market. Becton, Dickinson and Co. share today touched a day high of $145.47 and a low of $140.63.

What is the 52 week high and 52 week low for Becton, Dickinson and Co. share?

Becton, Dickinson and Co. share touched a 52 week high of $213.08 on and a 52 week low of $140.63 on . Becton, Dickinson and Co. stock price today i.e. is closed at $141.61,which is 33.54% down from its 52 week high and 0.70% up from its 52 week low.

What is Becton, Dickinson and Co.'s market capitalisation today?

Becton, Dickinson and Co. market capitalisation is $0.04T as on .

How to invest in Becton, Dickinson and Co. Stock (BDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Becton, Dickinson and Co. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Becton, Dickinson and Co. Shares that will get you 0.0106 shares as per Becton, Dickinson and Co. share price of $141.61 per share as on June 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy Becton, Dickinson and Co. Stock (BDX) from India?

Indian investors can start investing in Becton, Dickinson and Co. (BDX) shares with as little as ₹94.5 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in Becton, Dickinson and Co. stock (as per the Rupee-Dollar exchange rate as on ). Based on Becton, Dickinson and Co. share’s latest price of $141.61 as on June 18, 2026 at 8:45 am IST, you will get 0.0706 shares of Becton, Dickinson and Co.. Learn more about fractional shares .

What are the returns that Becton, Dickinson and Co. has given to Indian investors in the last 5 years?

Becton, Dickinson and Co. stock has given -41.13% share price returns and 27.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?